ETS1 and head and neck squamous cell carcinoma: Combined with the results in Fig. 1 that showed up-regulation of ETS-1 protein levels in a majority of cisplatin-resistant HNSCC cells, we concluded that the SRC/ETS-1 pathway was also enhanced in a majority of cisplatin-resistant HNSCC (Fig. 6a).